AstraZeneca

Watch out Tesaro, AstraZeneca and Merck get FDA OK for broad use of Lynparza
Endpoints
Thu, 08/17/17 - 11:54 pm
Tesaro
AstraZeneca
Merck
FDA
Lynparza
Zejula
The decade's top 10 patent losses, worth a whopping $915B in lifetime sales
Fierce Pharma
Thu, 08/17/17 - 10:36 am
patents
AbbVie
Humira
Pfizer
Lipitor
Norvasc
GSK
Advair
Sanofi
Lantus
JNJ
Remicade
AstraZeneca
Crestor
Nexium
Amgen
Neulasta
Novartis
Diovan
The 2017 report card so far: Big Biotech largely trading up as pharma posts mixed results
Fierce Pharma
Thu, 08/10/17 - 06:58 pm
pharma stocks
Merck
Pfizer
AbbVie
Eli Lilly
Bristol-Myers Squibb
GSK
Roche
Sanofi
Bayer
Novo Nordisk
Celgene
Biogen
AstraZeneca
Big Pharma veterans at Pfizer, AstraZeneca join the great migration to biotech
Endpoints
Fri, 08/4/17 - 11:41 am
Pfizer
AstraZeneca
Big Pharma
biotech
Following PhIII breakdown, AstraZeneca cruises toward an FDA decision for its BTK blockbuster hopeful acalabrutinib
Endpoints
Wed, 08/2/17 - 09:50 am
AstraZeneca
FDA
acalabrutinib
Btk inhibitors
Expecting Big Pharma buyers to come running after weakened AstraZeneca? Not so fast
Fierce Pharma
Tue, 08/1/17 - 11:12 pm
AstraZeneca
M&A
Pfizer
GlaxoSmithKline GLP-1 Tanzeum meets its end, and it doesn't bode well for Sanofi, AstraZeneca: analyst
Fierce Pharma
Tue, 08/1/17 - 10:48 pm
GSK
GLP-1 agonist
Tanzeum
Sanofi
AstraZeneca
AstraZeneca fights back in cancer with new hires, fast drug status
Yahoo/Reuters
Mon, 07/31/17 - 09:56 am
AstraZeneca
Imfinzi
immuno-oncology
Prescribed Reading: Pharma marked by restructuring and failures
BioPharma Dive
Fri, 07/28/17 - 10:40 pm
restructuring
M&A
AstraZeneca
Mystic
Bristol shrugs off comparisons to MYSTIC
BioPharma Dive
Fri, 07/28/17 - 11:38 am
AstraZeneca
Bristol-Myers Squibb
Mystic
immuno-oncology
Opdivo
AstraZeneca, Merck team up on Lynparza combos in collaboration worth up to $8.5B
Fierce Pharma
Fri, 07/28/17 - 11:31 am
AstraZeneca
Merck
Lynparza
Imfinzi
A humbling setback for an immune-revving cancer therapy underscores the many questions facing the field
Stat
Thu, 07/27/17 - 07:44 pm
AstraZeneca
Mystic
immuno-oncology
AstraZeneca Takeover Chatter Bubbles Up Again After Massive Drug Trial Disappointment
TheStreet.com
Thu, 07/27/17 - 11:56 am
AstraZeneca
Mystic
clinical trials
M&A
Pfizer
Merck
AstraZeneca Cancer Drug Failure Doesn't Bode Well For Bristol Myers
TheStreet.com
Thu, 07/27/17 - 11:07 am
AstraZeneca
clinical trials
Mystic
Bristol-Myers Squibb
Opdivo
AstraZeneca lung cancer immunotherapy trial failure sends shares plunging
Stat
Thu, 07/27/17 - 09:59 am
AstraZeneca
Mystic
immuno-oncology
clinical trials
tremelimumab
Imfinzi
These 2 Pharma Giants May Be on Pfizer's M&A Radar Right Now
Motley Fool
Wed, 07/26/17 - 11:22 am
Pfizer
M&A
AstraZeneca
Bristol-Myers Squibb
AstraZeneca CEO reassures staff, aims to be at September cancer meet
Reuters
Fri, 07/21/17 - 11:27 am
AstraZeneca
Pharma CEOs
Pascal Soriot
Teva Pharmaceutical
5 Big Pharma Stocks With the Best Drug Pipelines
Motley Fool
Tue, 07/18/17 - 11:32 am
Big Pharma
Roche
AstraZeneca
AbbVie
Gilead Sciences
JNJ
Will he stay or will he go? AZ's shares jump, Teva's sink on report that Soriot will stay put
Fierce Pharma
Fri, 07/14/17 - 03:46 pm
AstraZeneca
Pascal Soriot
Teva Pharmaceutical
Pharma CEOs
Cancer-fighting PARP drugs from AstraZeneca, Clovis and Tesaro largely overpriced, watchdog says
Fierce Pharma
Thu, 07/13/17 - 09:33 pm
PARP inhibitors
AstraZeneca
Clovis Oncology
Tesaro
drug pricing

Pages